News / Taiwan / economic_daily
Pei-Er Biomedical Hits Record High Ahead of 1-for-20 Stock Split
Health Technology · Biotechnology · economic_daily · 2026-08-26
6949
Pei-Er Biomedical shares surged to a record high of NT$1,490 as the company approaches its final trading day before a 1-for-20 stock split.
What Happened
Record Share Price: Pei-Er Biomedical reached a new all-time high of NT$1,490 today, cementing its position as a standout performer in the biotechnology sector. The rally is driven by both investor optimism regarding its pipeline and the upcoming corporate action involving a stock split.
Stock Split Details: The company is executing a 1-for-20 stock split, reducing the par value per share from NT$10 to NT$0.5. August 26 marks the final trading day for existing shares, with new shares expected to resume trading on September 7; the company's total market capitalization remains unchanged by this adjustment.
Clinical Pipeline: The company's lead product, PL001, is a CAR-T cell therapy targeting relapsed or refractory B-cell lymphoma. Having successfully passed the interim analysis of its Phase II clinical trial, the company is now focused on securing conditional drug approval to accelerate commercialization.
Investor Outlook: Investors are advised that the post-split share price will be adjusted proportionally to the split ratio, meaning the lower nominal price does not reflect a change in company value. Future performance will depend heavily on the progress of regulatory approvals and the successful commercial rollout of its CAR-T therapies.
Read original
More in Health Technology
Health Technology · economic_daily · 2026-08-26
Taiwan's biotech sector rallied on August 26, driven by clinical trial progress, international licensing deals, and medical device commercialization milestones.
4188, 6446, 6499, 6547, 6617, 6885, 6949
Health Technology · yonhap_finance · 2026-08-26
Nature Cell announced a 9.7 billion won investment to acquire additional shares in its U.S. subsidiary, securing a 100% stake to boost local operations.
007390
Health Technology · cnbc · 2026-08-25
The Department of Health and Human Services is considering adding two deputy commissioner positions to the FDA to bolster oversight of technology and pharmaceuticals.
QURE, REPL
Latest in Taiwan
Health Technology · economic_daily · 2026-08-26
Taiwan's biotech sector rallied on August 26, driven by clinical trial progress, international licensing deals, and medical device commercialization milestones.
4188, 6446, 6499, 6547, 6617, 6885, 6949
Electronic Technology · economic_daily · 2026-08-26
Hoya Vision, an AI-driven optical inspection company, has announced its IPO auction details, with a listing scheduled for September 10 on the Taipei Exchange.
7825
Finance · economic_daily · 2026-08-26
A strong performance in Taiwan's financial index has propelled ETFs with heavy financial sector exposure, with 00919 drawing significant investor attention.
0055, 00701, 00919, 00938, 00939
Electronic Technology · economic_daily · 2026-08-26
Atech has surged to its daily limit as investors bet on its strategic pivot toward high-frequency materials for AI servers and advanced semiconductor packaging.
4939